Personalization of Opioid Prescription Following Orthognathic Surgery

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

April 24, 2023

Primary Completion Date

May 30, 2024

Study Completion Date

May 1, 2026

Conditions
Pain, PostoperativeOrthognathic SurgeryOpioid UsePatient SatisfactionOpioid Use Disorder
Interventions
DRUG

Personalization of dose and frequency and instituting a tapering protocol of hydromorphone post-orthognathic surgery

POP participants will be given a personalized opioid prescription with a tapering protocol based on their last inpatient 24-hour usage of opioids, obtained from the nursing medication administration record. Should a participant stay in the hospital for less than 24 hours (e.g. patient had an early discharge at 18 hours), the 24-hour in-patient opioid usage would be extrapolated from their total amount and frequency of opioid use. The participant will be provided with an instruction card with suggestions on how much opioid to take at various time points following discharge to safely taper their medication.

DRUG

Standardized dose and frequency of hydromorphone with no tapering post-orthognathic surgery

SOP participants will be given a standardized dose of hydromorphone (2-4mg orally every 6 hours), and a total amount of 40mg. No further information is provided to them with regards to their pain medication and to tapering.

Trial Locations (1)

B3H 2Y9

Dalhousie University, Halifax

All Listed Sponsors
lead

Nova Scotia Health Authority

OTHER